Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2003
12/11/2003US20030228379 Herbs and herbal combinations useful for the treatment of microbial infections
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228357 Sizing, compaction, forming tablets
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003US20030228329 Genetic engineering; insertion of gene; generating immunology response
12/11/2003US20030228323 Protein vaccine; culture product; genetic engineering
12/11/2003US20030228321 Preventives for reinfection after liver transplantation
12/11/2003US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders
12/11/2003CA2706635A1 Camptothecins with a modified lactone ring
12/11/2003CA2488281A1 Novel bacterium for treatment of disease
12/11/2003CA2487918A1 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
12/11/2003CA2487895A1 Defensins: use as antiviral agents
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487679A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003CA2487678A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
12/11/2003CA2487509A1 New salts
12/11/2003CA2487299A1 Treatment of hepatitis c in the asian population with subcutaneous interferon-beta
12/11/2003CA2486980A1 Attenuated listeria spp. and methods for using the same
12/11/2003CA2486794A1 Pharmaceutical composition for controlled drug delivery system
12/11/2003CA2484972A1 Personal care article and method for inhibiting attachment of yeast to skin
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/10/2003EP1369489A1 Flavonoid compound and process for producing the same
12/10/2003EP1369426A1 Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
12/10/2003EP1369425A1 Thiopeptide compounds
12/10/2003EP1369420A1 Inhibitors of the GPib - vWF interaction
12/10/2003EP1369120A1 Treatment of flavivirus infection
12/10/2003EP1369118A1 Process and agent for the prevention, inhibition and therapy of sepsis
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368457A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
12/10/2003EP1368456A2 Anti-bacterial vaccine compositions
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368377A2 Modified interferon beta with reduced immunogenicity
12/10/2003EP1368373A2 Environmentally regulated genes, involved in the virulence of streptococcus suis
12/10/2003EP1368372A2 Peptides having affinity for the gp120 viral protein and use thereof
12/10/2003EP1368326A2 Oxazolidinone photoaffinity probes
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003EP1368304A1 Prodrugs of excitatory amino acids
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368061A2 Fusion cells and cytokine compositions for treatment of disease
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368050A2 Virus derived antimicrobial peptides
12/10/2003EP1368044A2 Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection
12/10/2003EP1368040A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
12/10/2003EP1368039A2 Aminoglycoside treatment for lysosomal storage diseases
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368010A2 Antibacterial compositions which contain oxapenem-3-carboxylic acids and antibiotics
12/10/2003EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability
12/10/2003EP1368004A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367980A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1154775B1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
12/10/2003EP1144420B1 Sulfated phosphatidylinositols, their preparation and use
12/10/2003EP1058687B1 Nucleosides
12/10/2003EP1049711B1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0824547B1 Anti-fungal peptides
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0651759B1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
12/10/2003CN1461338A Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461219A Non-sedating barbiturate compounds as neuroprotective agents
12/10/2003CN1461214A Compositions for improving skin environment and clothes thereof
12/10/2003CN1460676A Method for synthesizing pasiniazide
12/10/2003CN1460522A Egg yolk antibody composite for preventing and curing diseases and its preparaion method
12/10/2003CN1460521A Recombinant hepatitis B BCG vaccine combined vaccine and its preparation method
12/10/2003CN1460520A Compound alliin enteric solubility capsule
12/10/2003CN1460514A Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS
12/10/2003CN1460513A Jinlian Qingre capsule and its preparation method
12/10/2003CN1460512A Water-soluble propolis liquor and its preparation method
12/10/2003CN1460507A Compound jinlian soft capsule and its preparation method
12/10/2003CN1460503A Brandisia hancei soft capsule and its preparation method
12/10/2003CN1460497A Freeze-dried powder injection for curing hepatitis, large dise transfusion medicine and its preparation method
12/10/2003CN1460491A Medicine for curing diarrhea and red and white dysentery
12/10/2003CN1460484A Bacillus prodigiosus polysaccharide for nose drops
12/10/2003CN1460474A Application of geldanamycin in preparation of medicine for curing SARS
12/10/2003CN1460473A Application of brataxin in preparation of medicine for inhibiting AIDS virus
12/10/2003CN1130362C Nucleosides analogues, such as antivirals including inhititors of retroviral reverse transcriptase and DNA polymerase of heaptitis B virus (HBV)
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130345C Amino quinoline derivatives
12/10/2003CN1130227C Viral agent associated with mystery swine disease
12/10/2003CN1130225C Method for purifying necrotoxin produced by bordetella and toxoid
12/10/2003CN1130204C Pharmaceutical composition with antimicrobial activty
12/09/2003US6660891 Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom
12/09/2003US6660855 Crystal of diphenylmethyl 2-methyl-2-triazolylmethylpenam-3-carboxylate; given X-ray powder diffraction pattern; storage stability
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660747 Amido ether substituted imidazoquinolines
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660743 Improved stability
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
1 ... 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 ... 1798